74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
74%
of retail investor accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
74%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
I Insight Molecular Diagnostics
I
Closed
4.4 -2
Overview
Share price change
24h
Min
3.99
Max
4.5
Recommendations | Buy |
|---|---|
12 Months Forecast | +131.79% upside |
Next Earnings | 23 Mar 2026 |
|---|
Insight Molecular Diagnostics Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Insight Molecular Diagnostics Forecast
Price Target
By TipRanks
131.79% upside
12 Months Forecast
Average 10.5 USD 131.79%
High 12 USD
Low 9 USD
Based on 2 Wall Street analysts offering 12 month price targets forInsight Molecular Diagnostics - Dist in the last 3 months.
Financials
$
Live chat